77 related articles for article (PubMed ID: 4020537)
1. A reevaluation of psychotomimetic amphetamine derivatives in humans.
Cassels BK; Gómez-Jeria JS
J Psychoactive Drugs; 1985; 17(2):129-30. PubMed ID: 4020537
[No Abstract] [Full Text] [Related]
2. Profiles of psychedelic drugs: 10. DOB.
Shulgin A
J Psychoactive Drugs; 1981; 13(1):99. PubMed ID: 7277091
[No Abstract] [Full Text] [Related]
3. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
[No Abstract] [Full Text] [Related]
4. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
[No Abstract] [Full Text] [Related]
5. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
Jacob P; Shulgin AT
J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
[TBL] [Abstract][Full Text] [Related]
6. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
[No Abstract] [Full Text] [Related]
7. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
8. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
Commissaris RL; Semeyn DR; Moore KE; Rech RH
Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
[No Abstract] [Full Text] [Related]
9. QSAR studies on psychotomimetic phenylalkylamines.
Gupta SP; Handa A; Bindal MC; Singh P
Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
Shimamine M; Takahashi K; Nakahara Y
Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
[TBL] [Abstract][Full Text] [Related]
11. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.
Rasmussen K; Glennon RA; Aghajanian GK
Eur J Pharmacol; 1986 Dec; 132(1):79-82. PubMed ID: 3816969
[TBL] [Abstract][Full Text] [Related]
12. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
[No Abstract] [Full Text] [Related]
13. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
Glennon RA; Rosecrans JA; Young R; Gaines J
Life Sci; 1979 Mar; 24(11):993-7. PubMed ID: 286864
[No Abstract] [Full Text] [Related]
14. Further studies on BL-3912A: effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock.
Tilson HA; Chamberlain JH; Gylys JA
Pharmacol Biochem Behav; 1977 Jun; 6(6):627-30. PubMed ID: 263545
[TBL] [Abstract][Full Text] [Related]
15. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
Cheng HC; Long JP; Nichols DE; Barfknecht CF
J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
[No Abstract] [Full Text] [Related]
16. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
17. Effects of delta9-tetrahydrocannabinol & 2, 5-dimethoxy-4-methylamphetamine on rat sexual dominance behavior.
Uyeno ET
Proc West Pharmacol Soc; 1976; 19():369-72. PubMed ID: 996008
[No Abstract] [Full Text] [Related]
18. The effect of chirality on serotonin receptor affinity.
Glennon RA
Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
[No Abstract] [Full Text] [Related]
19. LSD or DOB?
Davis WM
Am J Psychiatry; 1982 Dec; 139(12):1649. PubMed ID: 7149079
[No Abstract] [Full Text] [Related]
20. Bromo-DMA: new hallucinogenic drug.
Delliou D
Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
